[Prognostic evaluation of heart-liver ratio of (99m)Tc-MIBI on liver cirrhosis]

Zhonghua Gan Zang Bing Za Zhi. 2000 Oct;8(5):264-5.
[Article in Chinese]

Abstract

Objective: To evaluate heart-liver ratio (H/L) of (99m)Tc-MIBI on the prognosis of cirrhotic patients.

Methods: Retrospective cohort study was used to analyze the survival rate among the patients who had received H/L detection, and the H/L value was classified by Child-Pugh class.

Results: All the patients were followed up for 0.1 to 63 months. H/L ratio was significantly different among Child-Pugh A, B, C groups (0.85 +/- 0.15, 0.99 +/- 0.19, 1.15 +/- 0.27, F=5.09, P<0.01); 6-month, 1-year, and 2-year survival rates in H/L<1.0 group were significantly higher than those in H/L>1.0 group (85.9%, 57.4%, 57. 4% vs 50.0%, 39.4%, 19.7%, P<0.01 ). Among patients with Child-Pugh degree C, 6-month, 1-year, and 2-year survival rates in H/L<1.0 group were significantly higher than those in H/L>1.0 group (71.4%, 42.9%, 42.9% vs 27.3%, 18.2%, 0).

Conclusion: H/L is an effective index for evaluating prognosis of cirrhotic patients, and it could be complemented by Child-Pugh classification.

MeSH terms

  • Adult
  • Aged
  • Female
  • Heart / diagnostic imaging*
  • Humans
  • Liver / diagnostic imaging*
  • Liver Cirrhosis / diagnostic imaging*
  • Liver Cirrhosis / mortality
  • Male
  • Middle Aged
  • Prognosis
  • Radionuclide Imaging
  • Survival Rate
  • Technetium Tc 99m Sestamibi*

Substances

  • Technetium Tc 99m Sestamibi